pH-sensitive
liposomes are designed to promote efficient release of entrapped agents in response to low pH. In this study, novel pH-sensitive
liposomes consisting of cationic/anionic
lipid combinations are evaluated for intracellular
drug and gene delivery. First,
liposomes composed of egg
phosphatidylcholine,
dimethyldioctadecylammonium bromide (
DDAB),
cholesteryl hemisuccinate (CHEMS), and Tween-80 (25:25:49:1, mol/mol) were shown to stably entrap
calcein at pH 7.4 and undergo rapid content release and irreversible aggregation under acidic pH. Compared to pH-sensitive
liposomes incorporating
dioleoylphosphatidylethanolamine, these
liposomes showed improved retention of pH-sensitivity in the presence of serum. The
folate receptor (FR), which is amplified in a wide variety of human
tumors, could be targeted by incorporating 0.1 mol%
folate-polyethyleneglycol-
phosphatidylethanolamine (f-
PEG-PE) into
liposomes. f-
PEG-PE has been shown to facilitate FR-mediated endocytosis of
liposomes into KB human
oral cancer cells, which express amplified FR. FR-targeted pH-sensitive
liposomes produced increased cytosolic release of entrapped
calcein, as shown by fluorescence microscopy, and enhanced cytotoxicity of entrapped
cytosine-beta-D-arabinofuranoside, as shown by an 11-fold reduction in the IC(50) in KB cells, compared to FR-targeted non-pH-sensitive
liposomes. Furthermore, FR-targeted pH-sensitive
liposomes composed of
DDAB/CHEMS/f-
PEG-PE, combined with
polylysine-condensed plasmid
DNA, were shown to mediate FR-specific delivery of a
luciferase reporter gene into KB cells in the presence of 10% serum. These findings suggest that cationic
lipid-containing pH-sensitive
liposomes, combined with FR targeting, are effective vehicles for intracellular
drug and gene delivery.